Published in Lab Business Week, July 12th, 2009
Luminex Corporation (NASDAQ: LMNX), the worldwide leader in multiplexed solutions, announced the full market release of its groundbreaking FLEXMAP 3DTM system, a high-throughput multiplexing instrument that allows scientists to simultaneously perform up to 500 tests on a single sample.
Created with input from scientists worldwide, FLEXMAP 3D was designed to meet the needs of medium and high-volume laboratories, such as academic, reference and pharmaceutical research laboratories. The FLEXMAP 3D multiplexing system's ability to conduct many tests...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.